News | July 24, 2024
Syngene reports drop in Q1 FY25 revenue to Rs. 790 Cr
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Reported profit after tax declined 19% year-on-year to Rs 76 crores
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
The academy has secured partnerships with 15 esteemed hospitals
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
This tie-up will have no impact on any other brands of the company
Subscribe To Our Newsletter & Stay Updated
